Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors

Bioorg Med Chem Lett. 2008 Jul 15;18(14):4087-91. doi: 10.1016/j.bmcl.2008.05.101. Epub 2008 Jul 2.

Abstract

The induction of conformationally restricted N-(aryl or heteroaryl)-3-azabicyclo[3.1.0]hexane derivatives at P(2) region of compounds of 2-cyanopyrrolidine class was explored to develop novel DPP-IV inhibitors. The synthesis, structure-activity relationship, and selectivity against related proteases are delineated.

MeSH terms

  • Amino Acid Motifs
  • Bridged Bicyclo Compounds, Heterocyclic / chemistry*
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cell Proliferation / drug effects
  • Chemistry, Pharmaceutical / methods
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / therapy
  • Dipeptidyl Peptidase 4 / chemistry
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Drug Design
  • Hexanes / chemistry*
  • Hexanes / pharmacology
  • Humans
  • Ligands
  • Models, Chemical
  • Molecular Conformation
  • Piperidines / chemistry
  • Protease Inhibitors / chemistry*
  • Protease Inhibitors / pharmacology*
  • Structure-Activity Relationship
  • T-Lymphocytes / drug effects*

Substances

  • 3-azabicyclo(3.1.0)hexane
  • Bridged Bicyclo Compounds, Heterocyclic
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hexanes
  • Ligands
  • Piperidines
  • Protease Inhibitors
  • Dipeptidyl Peptidase 4